TVP23A
gene geneOn this page
Also known as YDR084C
Summary
TVP23A (trans-golgi network vesicle protein 23 homolog A, HGNC:20398) is a protein-coding gene on chromosome 16p13.13, encoding Golgi apparatus membrane protein TVP23 homolog A (A6NH52).
This gene encodes a membrane protein associated with the Golgi apparatus, which plays a crucial role in intracellular vesicular transport. The encoded protein is likely associated with the late (trans) Golgi compartments, which are involved in the delivery of secretory and membrane proteins to the endosome, lysosome or the plasma membrane. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 780776 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_001079512
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20398 |
| Approved symbol | TVP23A |
| Name | trans-golgi network vesicle protein 23 homolog A |
| Location | 16p13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | YDR084C |
| Ensembl gene | ENSG00000166676 |
| Ensembl biotype | protein_coding |
| Entrez | 780776 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 8 protein_coding, 4 nonsense_mediated_decay, 3 protein_coding_CDS_not_defined
ENST00000299866, ENST00000456096, ENST00000570692, ENST00000572102, ENST00000572428, ENST00000572980, ENST00000573360, ENST00000573857, ENST00000575135, ENST00000619408, ENST00000649981, ENST00000851306, ENST00000922304, ENST00000922305, ENST00000922306
RefSeq mRNA: 2 — MANE Select: NM_001079512
NM_001079512, NM_001318873
CCDS: CCDS45408
Canonical transcript exons
ENST00000299866 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001490040 | 10818485 | 10818794 |
| ENSE00003467681 | 10774952 | 10775096 |
| ENSE00003487700 | 10771670 | 10771798 |
| ENSE00003542877 | 10773313 | 10773441 |
| ENSE00003596152 | 10818103 | 10818182 |
| ENSE00003636888 | 10774039 | 10774128 |
| ENSE00003789921 | 10770272 | 10770331 |
| ENSE00003849684 | 10766675 | 10769101 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 84.21.
FANTOM5 (CAGE): breadth broad, TPM avg 1.4707 / max 80.9913, expressed in 328 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 156220 | 0.6766 | 244 |
| 156222 | 0.5003 | 199 |
| 156223 | 0.1735 | 81 |
| 156217 | 0.0683 | 19 |
| 156221 | 0.0222 | 7 |
| 156216 | 0.0163 | 6 |
| 156218 | 0.0135 | 5 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 84.21 | gold quality |
| cortical plate | UBERON:0005343 | 83.04 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.63 | gold quality |
| endothelial cell | CL:0000115 | 80.00 | gold quality |
| ventricular zone | UBERON:0003053 | 79.01 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 78.88 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.79 | gold quality |
| ganglionic eminence | UBERON:0004023 | 78.50 | gold quality |
| right frontal lobe | UBERON:0002810 | 78.22 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.17 | gold quality |
| left ovary | UBERON:0002119 | 77.80 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 76.80 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 76.53 | silver quality |
| hypothalamus | UBERON:0001898 | 76.47 | gold quality |
| right ovary | UBERON:0002118 | 75.84 | gold quality |
| ovary | UBERON:0000992 | 75.48 | gold quality |
| neocortex | UBERON:0001950 | 75.37 | gold quality |
| nucleus accumbens | UBERON:0001882 | 75.07 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 75.05 | gold quality |
| primary visual cortex | UBERON:0002436 | 74.38 | gold quality |
| frontal cortex | UBERON:0001870 | 74.32 | gold quality |
| frontal lobe | UBERON:0016525 | 74.32 | gold quality |
| caudate nucleus | UBERON:0001873 | 73.68 | gold quality |
| amygdala | UBERON:0001876 | 73.66 | gold quality |
| cerebral cortex | UBERON:0000956 | 72.80 | gold quality |
| putamen | UBERON:0001874 | 72.05 | gold quality |
| adenohypophysis | UBERON:0002196 | 71.99 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 71.91 | gold quality |
| forebrain | UBERON:0001890 | 71.67 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.58 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
120 targeting TVP23A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tvp23a | ENSMUSG00000050908 |
| rattus_norvegicus | Tvp23a | ENSRNOG00000079813 |
| drosophila_melanogaster | CG5021 | FBGN0035944 |
| caenorhabditis_elegans | WBGENE00016400 |
Paralogs (2): TVP23B (ENSG00000171928), TVP23C (ENSG00000175106)
Protein
Protein identifiers
Golgi apparatus membrane protein TVP23 homolog A — A6NH52 (reviewed: A6NH52)
All UniProt accessions (5): A0A087WYU4, A6NH52, I3L109, I3L3Y3, I3L488
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the TVP23 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A6NH52-1 | 1 | yes |
| A6NH52-2 | 2 |
RefSeq proteins (2): NP_001072980, NP_001305802 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008564 | TVP23-like | Family |
Pfam: PF05832
UniProt features (6 total): transmembrane region 4, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NH52-F1 | 79.84 | 0.47 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 56 (showing top):
GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_SECRETION, MIKKELSEN_ES_ICP_WITH_H3K4ME3, DURAND_STROMA_S_UP, IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP, ZNF597_TARGET_GENES, MIR153_5P, MIR616_5P, MIR371B_5P, MIR373_5P, MIR6867_5P, MIR7856_5P, MIR4533, MIR4760_3P, MIR6876_5P
GO Biological Process (2): protein secretion (GO:0009306), vesicle-mediated transport (GO:0016192)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): Golgi membrane (GO:0000139), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein transport | 1 |
| secretion by cell | 1 |
| establishment of protein localization to extracellular region | 1 |
| protein localization to extracellular region | 1 |
| transport | 1 |
| cellular process | 1 |
| binding | 1 |
| Golgi apparatus | 1 |
| bounding membrane of organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
290 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TVP23A | FAM24A | A6NFZ4 | 507 |
| TVP23A | OR10H4 | Q8NGA5 | 507 |
| TVP23A | EPHX4 | Q8IUS5 | 489 |
| TVP23A | NEXMIF | Q5QGS0 | 478 |
| TVP23A | COP1 | Q8NHY2 | 465 |
| TVP23A | FBXL17 | Q9UF56 | 456 |
| TVP23A | GSC | P56915 | 451 |
| TVP23A | CACNA1I | Q9P0X4 | 440 |
| TVP23A | ZSCAN21 | Q9Y5A6 | 430 |
| TVP23A | PLA2G4F | Q68DD2 | 429 |
| TVP23A | LANCL3 | Q6ZV70 | 371 |
| TVP23A | SLC25A39 | Q9BZJ4 | 359 |
| TVP23A | FBXL13 | Q8NEE6 | 327 |
| TVP23A | SIRAL2 | Q9NWS6 | 325 |
| TVP23A | TENM1 | Q9UKZ4 | 318 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TVP23A | SCAND1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TVP23A | WIPF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TVP23A | LEPROTL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TVP23A | YIPF1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| WIPF2 | TVP23A | psi-mi:“MI:0915”(physical association) | 0.000 |
| SCAND1 | TVP23A | psi-mi:“MI:0915”(physical association) | 0.000 |
| TVP23A | LEPROTL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): TVP23A (Synthetic Lethality), TVP23A (Affinity Capture-RNA), TVP23A (Two-hybrid), SCAND1 (Two-hybrid), WIPF2 (Two-hybrid), YIPF1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GVZ9, A4IFN5, A5PK40, A6NH52, A6NI61, B2LYG4, B2RZC9, B6ID01, D2HKB0, D3ZG27, P86229, Q0VDI3, Q15012, Q15546, Q17QJ2, Q1RLT2, Q2TA01, Q4R4I5, Q4R6E8, Q5H8A4, Q5R7Q1, Q5RAH0, Q5RL79, Q5U3C3, Q5VTY9, Q5ZML7, Q64232, Q6PHN7, Q6QRN8, Q719N3, Q71SV0, Q8BWB6, Q8IY49, Q8N6M3, Q8NFT2, Q8R189, Q8VD53, Q8VDI9, Q8VDR5, Q9CQC4
Diamond homologs: A1CIM7, A1CW41, A2Q9P5, A3LRT4, A4RME3, A5DRE8, A6NH52, A6SFL7, A6ZY50, A7TGB4, A8N1Z1, B0CQN9, B0Y4Q8, B2ALT5, P38962, Q0CSZ7, Q0UV43, Q18449, Q1E9X9, Q29S14, Q2UUK2, Q4WQJ5, Q54LC9, Q5APA2, Q5R9I4, Q6BVH1, Q6C7V5, Q6CTK9, Q6FM91, Q74ZP5, Q7SGB6, Q8IQC1, Q8LEK2, Q96ET8, Q9D8T4, Q9NYZ1, Q9Y7K7, Q86I95, Q8N769
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 40 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2736 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:10761359:CGTA:C | acceptor_loss | 1.0000 |
| 16:10761360:GTAG:G | acceptor_loss | 1.0000 |
| 16:10761361:TA:T | acceptor_loss | 1.0000 |
| 16:10761362:A:AG | acceptor_gain | 1.0000 |
| 16:10761362:A:AT | acceptor_loss | 1.0000 |
| 16:10761362:AGGAG:A | acceptor_gain | 1.0000 |
| 16:10761363:G:GG | acceptor_gain | 1.0000 |
| 16:10761363:GGA:G | acceptor_gain | 1.0000 |
| 16:10761363:GGAGG:G | acceptor_gain | 1.0000 |
| 16:10761472:AAG:A | donor_loss | 1.0000 |
| 16:10761474:GGTG:G | donor_loss | 1.0000 |
| 16:10761475:G:T | donor_loss | 1.0000 |
| 16:10763761:CAT:C | acceptor_gain | 1.0000 |
| 16:10763763:TC:T | acceptor_loss | 1.0000 |
| 16:10763764:C:CC | acceptor_gain | 1.0000 |
| 16:10763765:T:C | acceptor_loss | 1.0000 |
| 16:10771669:CCGT:C | donor_gain | 1.0000 |
| 16:10773442:C:CA | acceptor_loss | 1.0000 |
| 16:10773443:T:C | acceptor_loss | 1.0000 |
| 16:10774041:T:A | donor_gain | 1.0000 |
| 16:10774124:ACATT:A | acceptor_gain | 1.0000 |
| 16:10774125:CATT:C | acceptor_gain | 1.0000 |
| 16:10774125:CATTC:C | acceptor_gain | 1.0000 |
| 16:10774127:TT:T | acceptor_gain | 1.0000 |
| 16:10774129:C:CC | acceptor_gain | 1.0000 |
| 16:10818116:T:A | donor_gain | 1.0000 |
| 16:10761354:A:AG | acceptor_gain | 0.9900 |
| 16:10761359:C:CA | acceptor_gain | 0.9900 |
| 16:10761362:AG:A | acceptor_gain | 0.9900 |
| 16:10761363:GG:G | acceptor_gain | 0.9900 |
AlphaMissense
1412 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:10774952:C:A | K78N | 0.997 |
| 16:10774952:C:G | K78N | 0.997 |
| 16:10773363:A:G | W135R | 0.995 |
| 16:10773363:A:T | W135R | 0.995 |
| 16:10774095:A:G | W90R | 0.995 |
| 16:10774095:A:T | W90R | 0.995 |
| 16:10774118:C:T | G82E | 0.995 |
| 16:10773394:G:C | F124L | 0.994 |
| 16:10773394:G:T | F124L | 0.994 |
| 16:10773396:A:G | F124L | 0.994 |
| 16:10774126:A:C | N79K | 0.993 |
| 16:10774126:A:T | N79K | 0.993 |
| 16:10774964:G:C | F74L | 0.993 |
| 16:10774964:G:T | F74L | 0.993 |
| 16:10774966:A:G | F74L | 0.993 |
| 16:10774100:A:G | L88P | 0.992 |
| 16:10774968:T:A | D73V | 0.992 |
| 16:10775052:G:T | A45D | 0.992 |
| 16:10771752:C:T | G167D | 0.991 |
| 16:10771760:G:C | N164K | 0.991 |
| 16:10771760:G:T | N164K | 0.991 |
| 16:10774118:C:A | G82V | 0.991 |
| 16:10774119:C:G | G82R | 0.991 |
| 16:10774119:C:T | G82R | 0.991 |
| 16:10774051:A:C | F104L | 0.990 |
| 16:10774051:A:T | F104L | 0.990 |
| 16:10774053:A:G | F104L | 0.990 |
| 16:10775054:A:C | S44R | 0.990 |
| 16:10775054:A:T | S44R | 0.990 |
| 16:10775056:T:G | S44R | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000001403 (16:10817706 G>A), RS1000004819 (16:10784702 C>T), RS1000007251 (16:10809774 C>T), RS1000036157 (16:10795326 C>T), RS1000043470 (16:10762721 A>G), RS1000161348 (16:10815010 C>T), RS1000186172 (16:10756971 T>C), RS1000237357 (16:10781572 C>G), RS1000245063 (16:10804873 A>T), RS1000317748 (16:10782679 T>A), RS1000350360 (16:10810301 C>A), RS1000428908 (16:10771636 G>A), RS1000456266 (16:10792285 C>T), RS1000498411 (16:10759843 C>G,T), RS1000505338 (16:10791516 C>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_1121 | Metabolite levels | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010523 | phosphoglyceric acid measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases methylation | 6 |
| trichostatin A | affects cotreatment, decreases expression | 3 |
| bisphenol A | decreases expression, decreases methylation | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| sulforaphane | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Panobinostat | affects cotreatment, decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.